Futility, benefit, and transcatheter aortic valve replacement
BR Lindman, KP Alexander, PT O'Gara… - JACC: Cardiovascular …, 2014 - jacc.org
Transcatheter aortic valve replacement (TAVR) is a transformative innovation that provides
treatment for high or prohibitive surgical risk patients with symptomatic severe aortic stenosis …
treatment for high or prohibitive surgical risk patients with symptomatic severe aortic stenosis …
Futility, benefit, and transcatheter aortic valve replacement.
BR Lindman, KP Alexander, PT O'Gara… - JACC. Cardiovascular …, 2014 - europepmc.org
Transcatheter aortic valve replacement (TAVR) is a transformative innovation that provides
treatment for high or prohibitive surgical risk patients with symptomatic severe aortic stenosis …
treatment for high or prohibitive surgical risk patients with symptomatic severe aortic stenosis …
[HTML][HTML] Futility, Benefit, and Transcatheter Aortic Valve Replacement
BR Lindman, KP Alexander, PT O'Gara… - JACC: Cardiovascular …, 2014 - Elsevier
Transcatheter aortic valve replacement (TAVR) is a transformative innovation that provides
treatment for high or prohibitive surgical risk patients with symptomatic severe aortic stenosis …
treatment for high or prohibitive surgical risk patients with symptomatic severe aortic stenosis …
Futility, benefit, and transcatheter aortic valve replacement
BR Lindman, KP Alexander… - JACC …, 2014 - pubmed.ncbi.nlm.nih.gov
Transcatheter aortic valve replacement (TAVR) is a transformative innovation that provides
treatment for high or prohibitive surgical risk patients with symptomatic severe aortic stenosis …
treatment for high or prohibitive surgical risk patients with symptomatic severe aortic stenosis …
Futility, Benefit, and Transcatheter Aortic Valve Replacement
BR Lindman, KP Alexander, PT O'Gara, J Afilalo… - JACC: Cardiovascular …, 2014 - infona.pl
Transcatheter aortic valve replacement (TAVR) is a transformative innovation that provides
treatment for high or prohibitive surgical risk patients with symptomatic severe aortic stenosis …
treatment for high or prohibitive surgical risk patients with symptomatic severe aortic stenosis …
[HTML][HTML] Futility, Benefit, and Transcatheter Aortic Valve Replacement
BR Lindman, KP Alexander, PT O'Gara… - JACC. Cardiovascular …, 2014 - ncbi.nlm.nih.gov
Transcatheter aortic valve replacement (TAVR) is a transformative innovation that provides
treatment for high or prohibitive surgical risk patients with symptomatic severe aortic stenosis …
treatment for high or prohibitive surgical risk patients with symptomatic severe aortic stenosis …
[引用][C] Futility, Benefit, and Transcatheter Aortic Valve Replacement
BR Lindman, KP Alexander, PT O'Gara… - JACC: Cardiovascular …, 2014 - cir.nii.ac.jp
Futility, Benefit, and Transcatheter Aortic Valve Replacement | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
Futility, benefit, and transcatheter aortic valve replacement.
BR Lindman, KP Alexander, PT O'Gara… - JACC. Cardiovascular …, 2014 - europepmc.org
Transcatheter aortic valve replacement (TAVR) is a transformative innovation that provides
treatment for high or prohibitive surgical risk patients with symptomatic severe aortic stenosis …
treatment for high or prohibitive surgical risk patients with symptomatic severe aortic stenosis …